These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28262738)

  • 1. High glucose levels boost the aggressiveness of highly metastatic cholangiocarcinoma cells via O-GlcNAcylation.
    Phoomak C; Vaeteewoottacharn K; Silsirivanit A; Saengboonmee C; Seubwai W; Sawanyawisuth K; Wongkham C; Wongkham S
    Sci Rep; 2017 Mar; 7():43842. PubMed ID: 28262738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-GlcNAc-induced nuclear translocation of hnRNP-K is associated with progression and metastasis of cholangiocarcinoma.
    Phoomak C; Park D; Silsirivanit A; Sawanyawisuth K; Vaeteewoottacharn K; Detarya M; Wongkham C; Lebrilla CB; Wongkham S
    Mol Oncol; 2019 Feb; 13(2):338-357. PubMed ID: 30444036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic insights of O-GlcNAcylation that promote progression of cholangiocarcinoma cells via nuclear translocation of NF-κB.
    Phoomak C; Vaeteewoottacharn K; Sawanyawisuth K; Seubwai W; Wongkham C; Silsirivanit A; Wongkham S
    Sci Rep; 2016 Jun; 6():27853. PubMed ID: 27290989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. O-GlcNAcylation mediates metastasis of cholangiocarcinoma through FOXO3 and MAN1A1.
    Phoomak C; Silsirivanit A; Park D; Sawanyawisuth K; Vaeteewoottacharn K; Wongkham C; Lam EW; Pairojkul C; Lebrilla CB; Wongkham S
    Oncogene; 2018 Oct; 37(42):5648-5665. PubMed ID: 29915392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of O-GlcNAc and GFAT expression by nicotine exposure promotes epithelial-mesenchymal transition and invasion in breast cancer cells.
    Zhang N; Zhu T; Yu K; Shi M; Wang X; Wang L; Huang T; Li W; Liu Y; Zhang J
    Cell Death Dis; 2019 Apr; 10(5):343. PubMed ID: 31019204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Vimentin Is Critical to Promote a Metastatic Potential of Cholangiocarcinoma Cells.
    Saentaweesuk W; Araki N; Vaeteewoottacharn K; Silsirivanit A; Seubwai W; Talabnin C; Muisuk K; Sripa B; Wongkham S; Okada S; Wongkham C
    Oncol Res; 2018 May; 26(4):605-616. PubMed ID: 28762325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High glucose enhances progression of cholangiocarcinoma cells via STAT3 activation.
    Saengboonmee C; Seubwai W; Pairojkul C; Wongkham S
    Sci Rep; 2016 Jan; 6():18995. PubMed ID: 26743134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin Exerts Antiproliferative and Anti-metastatic Effects Against Cholangiocarcinoma Cells by Targeting STAT3 and NF-ĸB.
    Saengboonmee C; Seubwai W; Cha'on U; Sawanyawisuth K; Wongkham S; Wongkham C
    Anticancer Res; 2017 Jan; 37(1):115-123. PubMed ID: 28011481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-21 regulates biological behavior by inducing EMT in human cholangiocarcinoma.
    Liu Z; Jin ZY; Liu CH; Xie F; Lin XS; Huang Q
    Int J Clin Exp Pathol; 2015; 8(5):4684-94. PubMed ID: 26191158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High glucose upregulates FOXM1 expression via EGFR/STAT3 dependent activation to promote progression of cholangiocarcinoma.
    Detarya M; Thaenkaew S; Seubwai W; Indramanee S; Phoomak C; Saengboonmee C; Wongkham S; Wongkham C
    Life Sci; 2021 Apr; 271():119114. PubMed ID: 33513399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide Induces GFAT2 Expression to Promote
    Al-Mukh H; Baudoin L; Bouaboud A; Sanchez-Salgado JL; Maraqa N; Khair M; Pagesy P; Bismuth G; Niedergang F; Issad T
    J Immunol; 2020 Nov; 205(9):2499-2510. PubMed ID: 32978282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characterization of a novel human cholangiocarcinoma cell line with high metastatic activity.
    Uthaisar K; Vaeteewoottacharn K; Seubwai W; Talabnin C; Sawanyawisuth K; Obchoei S; Kraiklang R; Okada S; Wongkham S
    Oncol Rep; 2016 Sep; 36(3):1435-46. PubMed ID: 27461717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibiting the Hexosamine Biosynthetic Pathway Lowers O-GlcNAcylation Levels and Sensitizes Cancer to Environmental Stress.
    Walter LA; Lin YH; Halbrook CJ; Chuh KN; He L; Pedowitz NJ; Batt AR; Brennan CK; Stiles BL; Lyssiotis CA; Pratt MR
    Biochemistry; 2020 Sep; 59(34):3169-3179. PubMed ID: 31625393
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Silva-Aguiar RP; Bezerra NCF; Lucena MC; Sirtoli GM; Sudo RT; Zapata-Sudo G; Takiya CM; Pinheiro AAS; Dias WB; Caruso-Neves C
    J Biol Chem; 2018 Aug; 293(33):12749-12758. PubMed ID: 29954945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The O-GalNAcylating enzyme GALNT5 mediates carcinogenesis and progression of cholangiocarcinoma via activation of AKT/ERK signaling.
    Detarya M; Sawanyawisuth K; Aphivatanasiri C; Chuangchaiya S; Saranaruk P; Sukprasert L; Silsirivanit A; Araki N; Wongkham S; Wongkham C
    Glycobiology; 2020 Apr; 30(5):312-324. PubMed ID: 31868214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac O-GlcNAc signaling is increased in hypertrophy and heart failure.
    Lunde IG; Aronsen JM; Kvaløy H; Qvigstad E; Sjaastad I; Tønnessen T; Christensen G; Grønning-Wang LM; Carlson CR
    Physiol Genomics; 2012 Feb; 44(2):162-72. PubMed ID: 22128088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Swim-exercised mice show a decreased level of protein O-GlcNAcylation and expression of O-GlcNAc transferase in heart.
    Belke DD
    J Appl Physiol (1985); 2011 Jul; 111(1):157-62. PubMed ID: 21493720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of O-GlcNAc-transferase associates with aggressiveness of mass-forming cholangiocarcinoma.
    Phoomak C; Silsirivanit A; Wongkham C; Sripa B; Puapairoj A; Wongkham S
    Asian Pac J Cancer Prev; 2012; 13 Suppl():101-5. PubMed ID: 23480751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
    Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S
    Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of O-GlcNAcylated proteins in invasive ductal breast carcinomas with and without lymph node metastasis.
    Jiang K; Gao Y; Hou W; Tian F; Ying W; Li L; Bai B; Hou G; Wang PG; Zhang L
    Amino Acids; 2016 Feb; 48(2):365-74. PubMed ID: 26374642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.